Document Detail

Economic burden of cardiovascular events and fractures among patients with end-stage renal disease.
MedLine Citation:
PMID:  17555611     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To quantify direct medical costs of fractures and cardiovascular diseases among end-stage renal disease (ESRD) patients. METHODS: Medicare claims data from year 2001 of the United States Renal Data System were used to quantify direct medical costs of acute episodic events (acute myocardial infarction (MI), stroke, heart valve repair, heart valve replacement, fractures) and chronic conditions (arrhythmia, peripheral vascular disease (PVD), heart valve disease (HVD), congestive heart failure (CHF), coronary heart disease, and non-acute stroke). Costs of hospitalized episodes of arrhythmia, PVD, CHF, and angina were also quantified. For acute events, costs were quantified using an episode-of-care approach. For chronic conditions, annualized costs were reported. Only costs specific to the events or conditions of interest were included and reported, in 2006 US dollars. Drug and dialysis-related costs were excluded. Diagnosis and procedure codes were used to identify these events and conditions. RESULTS: Among acute events analyzed as clinical episodes, PVD ($358 million) was associated with the greatest economic burden, followed by CHF, arrhythmia, angina, acute MI, heart valve replacement, hip fracture, acute stroke, heart valve repair, vertebral fracture, and pelvic fracture ($8.6 million). The cost per episode ranged from approximately $12,000 to 104,000. Among chronic conditions, CHF ($681 million) contributed the greatest economic burden; HVD ($100 million) contributed the least. The costs per patient-year ranged from $23,000 to 45,000 among chronic conditions. The costing methodology utilized could contribute to an underestimate of the economic impact of each condition; therefore these results are considered conservative. CONCLUSION: The economic burden of these selected conditions was substantial to health services payers who finance ESRD patient care. Episodic costs were high for most acute events.
Quan V Doan; Michelle Gleeson; John Kim; Rohit Borker; Robert Griffiths; Robert W Dubois
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Current medical research and opinion     Volume:  23     ISSN:  1473-4877     ISO Abbreviation:  Curr Med Res Opin     Publication Date:  2007 Jul 
Date Detail:
Created Date:  2007-08-02     Completed Date:  2007-09-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0351014     Medline TA:  Curr Med Res Opin     Country:  England    
Other Details:
Languages:  eng     Pagination:  1561-9     Citation Subset:  IM    
Cerner LifeSciences, 9100 Wilshire Blvd, Suite 655E, Beverly Hills, CA 90212, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiovascular Diseases / classification,  economics*
Costs and Cost Analysis
Fractures, Bone / classification,  economics*
Health Care Costs*
Hospitalization / economics
Kidney Failure, Chronic / complications*
United States

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Preconditioning and protection against ischaemia-reperfusion in non-cardiac organs: a place for vola...
Next Document:  Infrared-ultraviolet sum-frequency generation spectrometer with a wide tunability of the ultraviolet...